LATE-BREAKING ABSTRACT: Oral solithromycin has a favorable profile versus oral moxifloxacin for treatment of adult community-acquired pneumonia (CABP) in elderly patients and those with COPD or asthma
David Oldach (Chapel Hill, United States of America), David Oldach, Carlos Luna, Peter Szabo, Ismail Mitha, Cristina Tanaseanu, Alexis Doreski, Carlos Barrera, Anita Das, Kara Keedy, Brian Jamieson, Prabhavathi Fernandes
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Oldach (Chapel Hill, United States of America), David Oldach, Carlos Luna, Peter Szabo, Ismail Mitha, Cristina Tanaseanu, Alexis Doreski, Carlos Barrera, Anita Das, Kara Keedy, Brian Jamieson, Prabhavathi Fernandes. LATE-BREAKING ABSTRACT: Oral solithromycin has a favorable profile versus oral moxifloxacin for treatment of adult community-acquired pneumonia (CABP) in elderly patients and those with COPD or asthma. Eur Respir J 2015; 46: Suppl. 59, 2655
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: